hyaluronoglucosaminidase has been researched along with Stomach Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Ajani, J; Al-Sakaff, N; Allen, S; Alsina Maqueda, M; Cha, E; Gan, X; Kim, KP; Ko, AH; Lacy, J; Lau, J; Lee, J; Lopez, CD; Lu, D; Macarulla, T; Manji, GA; O'Reilly, EM; Oh, DY; Rha, SY; Shemesh, CS; Siveke, JT | 1 |
Aoyama, T; Cho, H; Fujikawa, H; Hara, K; Hashimoto, I; Hiroshima, Y; Ito, H; Kano, K; Kimura, Y; Maezawa, Y; Masuda, M; Miyagi, Y; Morinaga, S; Ogata, T; Oneyama, M; Oshima, T; Oue, N; Rino, Y; Sakamoto, N; Shiozawa, M; Tamagawa, H; Yamada, T; Yamamoto, N; Yasui, W; Yoshikawa, T; Yukawa, N | 1 |
Guo, H; Hou, X; Liu, S; Qin, T; Ren, L; Yang, J; Zhao, Q | 1 |
Feng, Z; Hu, W; Liu, J; Song, M; Zheng, X; Zhou, X | 1 |
Feng, M; Feng, X; Feng, Y; Hu, Y; Ji, J; Ji, K; Jia, S; Jiang, W; Li, W; Li, Z; Ma, R; Qu, T; Wang, X; Yang, Y | 1 |
Li, M; Li, W; Wang, L; Xiao, B; Yu, T; Zou, Q; Zuo, Q | 1 |
De Velasco, MA; Fujita, Y; Nishio, K; Sakai, K; Terashima, M; Togashi, Y; Tomida, S | 1 |
Fujibuchi, W; Gotoh, O; Horii, A; Kaneko, N; Kinouchi, M; Kobayashi, T; Miura, K; Miyagawa, K; Mizoi, T; Nagasaki, H; Ohnuma, S; Okabe, M; Sasaki, H; Sasaki, I; Shiiba, K; Tsukamoto, N | 1 |
Inoue, H; Matsuzaki, S; Mimori, K; Mori, M; Tahara, K; Tanaka, F | 1 |
Banerjee, SD; Kollapalli, SP; Mortha, KK; Srinivas, P; Thomas, A | 1 |
ROGERS, HJ | 1 |
PAVLIUSHCHIK, AV | 1 |
Cui, YH; Dong, W; Sun, H; Wu, T; Xu, HM | 1 |
1 trial(s) available for hyaluronoglucosaminidase and Stomach Neoplasms
Article | Year |
---|---|
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Humans; Hyaluronoglucosaminidase; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms | 2023 |
12 other study(ies) available for hyaluronoglucosaminidase and Stomach Neoplasms
Article | Year |
---|---|
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.
Topics: Aged; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Digestive System Surgical Procedures; Drug Combinations; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Invasiveness; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Analysis; Tegafur; Up-Regulation | 2019 |
Prognostic marker identification based on weighted gene co-expression network analysis and associated
Topics: Biomarkers, Tumor; Computational Biology; Gene Expression Profiling; Humans; Hyaluronoglucosaminidase; Prognosis; Stomach Neoplasms; Transcriptome | 2021 |
MiR-148a-3p targets CEMIP to suppress the genesis of gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; MicroRNAs; Stomach Neoplasms | 2021 |
KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Topics: Aged; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Isoenzymes; Male; Matrix Metalloproteinase 2; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Proteins; RNA, Small Interfering; Stomach Neoplasms; Survival Analysis; Wnt Signaling Pathway | 2017 |
The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Male; Mice; MicroRNAs; Neoplasm Proteins; Neoplasm Transplantation; Nuclear Proteins; Protein Tyrosine Phosphatases; Proteins; RNA Splicing Factors; Stomach Neoplasms; Up-Regulation; Wnt Signaling Pathway | 2019 |
KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Glycogen; Humans; Hyaluronoglucosaminidase; Liver Neoplasms; Phosphorylase Kinase; Protein Subunits; Proteins; Stomach Neoplasms; Transfection; Up-Regulation | 2014 |
Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues.
Topics: Adult; Aged; Alternative Splicing; Case-Control Studies; Cell Adhesion Molecules; Cell Culture Techniques; Cell Cycle Proteins; Cell Line, Tumor; Female; Genetic Variation; GPI-Linked Proteins; GTP-Binding Proteins; GTPase-Activating Proteins; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Prostatic Secretory Proteins; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms | 2009 |
Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer.
Topics: Cell Line, Tumor; Disease Progression; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Prognosis; Proteins; Stomach Neoplasms | 2009 |
Bioactive hyaluronan fragment (hexasaccharide) detects specific hexa-binding proteins in human breast and stomach cancer: possible role in tumorogenesis.
Topics: Breast Neoplasms; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Oligosaccharides; Receptors, Cell Surface; Stomach Neoplasms; Substrate Specificity | 2012 |
Variant populations within a hyaluronidase-producing culture of Staphylococcus aureus.
Topics: Hyaluronoglucosaminidase; Micrococcus; Staphylococcal Infections; Staphylococcus aureus; Stomach Neoplasms | 1953 |
[HYALURONIDASE ACTIVITY OF THE BLOOD SERUM OF PATIENTS WITH GASTRIC CANCER AND ULCER DURING THE PRE- AND POSTOPERATIVE PERIODS].
Topics: Blood Chemical Analysis; Gastrectomy; Humans; Hyaluronoglucosaminidase; Postoperative Period; Serum; Stomach Neoplasms; Stomach Ulcer; Ulcer | 1963 |
[Inhibitory effect of hyaluronic acid, hyaluronidase and RGD on adhesion and invasion of human gastric cancer cell line SGC7901].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Drug Synergism; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Integrin beta1; Mice; Neoplasm Invasiveness; NIH 3T3 Cells; Oligopeptides; Stomach Neoplasms | 2004 |